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Rickettsial diseases are caused by the obligate intracellular bacteria in the order Rickettsiales that can be 
transmitted to humans via the bites of fleas, 
lice, ticks or mites.1,2 Australia has several 
endemic rickettsial diseases: flea-borne 
murine typhus (R. typhi) and cat flea typhus 
(R. felis); mite-borne scrub typhus (Orientia 
tsutsugamushi); and the tick-borne spotted 
fever group (SFG), which includes Queensland 
tick typhus (R. australis), Flinders Island 
spotted fever (FISF; R. honei), and Australian 
spotted fever (R. honei subsp. marmionii).1,3,4 
Epidemic typhus (R. prowazekii) occurred in 
Australia in the 18th and 19th centuries but is 
no longer endemic.1,5
Tasmania (population 524,700)6 is an island 
state of Australia located 240 kilometres 
south of the mainland, consisting of the 
main island of Tasmania and several small, 
sparsely populated surrounding islands. FISF, 
the rickettsial infection typically associated 
with Tasmania, was first described in 1991 on 
Flinders Island, an island in Bass Strait off the 
north-east tip of Tasmania, by the island’s sole 
general practitioner (GP), Robert Stewart, who 
had identified 26 cases of a spotted-fever-like 
illness over 17 years.7 The causative agent has 
been identified as R. honei,1,8 and the reptile 
associated tick Bothriocroton hydrosauri 
(Southern Reptile Tick, formerly Aponomma 
hydrosauri), which commonly feeds from 
native reptiles such as blue-tongued lizards 
and snakes, has been confirmed as its host 
(Figure 1).9,10 Cases have not only been 
observed on Flinders Island, but also on 
Schouten Island, Tasmania, and in south-
eastern South Australia, where B. hydrosauri 
are also endemic.11 Additionally, two cases of 
locally acquired R. honei infection have been 
described in Western Australia,12 while cases 
have also been described internationally.13 
Symptoms can include sudden onset fever 
and chills, myalgia, transient arthralgia and 
a maculopapular rash.7 Treatment is usually 
with oral doxycycline;2 however, azithromycin 
and rifampicin have also been used 
successfully.
Rickettsial infection is not nationally notifiable 
in Australia under the National Notifiable 
Disease Surveillance System (NNDSS), 
but surveillance currently occurs in three 
jurisdictions. Epidemic typhus caused by R. 
prowazekii is notifiable in New South Wales, 
while rickettsial infection is notifiable in 
Western Australia and Tasmania. In Tasmania, 
cases are notifiable under the Public Health 
Act 1997.14 Positive rickettsial serology results 
(antibody titre ≥1:128 to a rickettsial group 
antigen) occurring in Tasmanian laboratories 
are forwarded to the Communicable Disease 
Prevention Unit (CDPU) and investigated. 
Standardised data collection on cases of 
rickettsiosis notified to CDPU was introduced 
at the beginning of 2012.
The existing literature on rickettsial infection 
in Tasmania describes cases of FISF on 
Flinders Island, one case on Schouten Island11 
and a case of rickettsiosis, assumed to be  
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Abstract
Objective: To describe the epidemiology and clinical characteristics of Tasmania-acquired 
rickettsial disease notified to the Department of Health in Tasmania from 2012 to 2017 
inclusive.
Methods: Data on rickettsiosis cases acquired and notified in Tasmania between 1 January 2012 
and 31 December 2017 were analysed descriptively.
Results: Eighteen cases of rickettsial infection notified in Tasmania 2012–17 and likely acquired 
in the state met one of three case definitions: 12 confirmed (67%), four probable (22%), and 
two possible (11%). The mean number of cases per year was 3.0 (population rate 0.6 per 
100,000 population/year); 60% of cases occurred in November and December. Cases were 
more commonly older males. Fever, lethargy, and rash were commonly reported symptoms. 
Thirteen cases were likely acquired on Flinders Island, three around Great Oyster Bay and two in 
the Midlands.
Conclusions: This study extends our knowledge of the epidemiology of rickettsial disease 
in Tasmania. This is the first account including confirmed cases acquired in the Midlands of 
Tasmania.
Implications for public health: Increased knowledge and awareness of epidemiology of 
rickettsial infection in Tasmania is essential for timely diagnosis and appropriate treatment. 
These findings bear wider relevance outside Tasmania because visitors may also be at risk.
Key words: Rickettsia, infectious diseases, epidemiology, surveillance, Flinders Island spotted 
fever
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R. honei, acquired on the Freycinet Peninsula 
or Maria Island.15 However, the geographical 
distribution and other epidemiological 
characteristics of rickettsial disease in 
Tasmania outside of Flinders Island are not 
well understood. A cluster of four rickettsial 
infection cases was identified on Flinders 
Island in December 2017, prompting the 
authors to review the surveillance data. The 
aim of this study was to review all rickettsiosis 
notifications in Tasmania over the six years 
from 2012 to 2017 inclusive and report the 




Confirmed, probable, and possible 
rickettsiosis cases notified to CDPU between 
1 January 2012, when the standardised 
case report form was introduced, and 31 
December 2017, were included. Cases where 
travel history was unknown or that were 
likely acquired outside of Tasmania, based 
on overseas or interstate travel during the 
exposure period, were excluded. Confirmed 
cases required laboratory definitive evidence, 
including detection (culture or nucleic 
acid test) of Rickettsia species in a clinical 
specimen, or seroconversion or a fourfold 
or greater rise in serum antibody titre to 
rickettsial group antigen between acute and 
convalescent phase sera specimens. Probable 
cases required clinical evidence and a single 
elevated antibody titre of equal to or greater 
than 1:256 to a rickettsial group antigen. 
Possible cases required clinical evidence and 
a single antibody titre of 1:128 to a rickettsial 
group antigen. Clinical evidence was defined 
as a clinically compatible illness (fever and 
at least one of headache, myalgia, rash, or 
eschar). 
Data collection
Rickettsial infections were notified to CDPU 
by Tasmanian laboratories and followed 
up within five days of notification. Further 
details about the illness, contact details, 
and permission to contact the patient 
were obtained from the testing clinician. 
A questionnaire was administered via 
telephone to the patient by a public health 
nurse or doctor, collecting information on 
demographics, clinical details of the illness, 
history of rickettsial infection and travel 
history (overseas, interstate, and intrastate). If 
only one serology test had been performed, 
a repeat serology two weeks later was 
recommended to confirm the diagnosis. 
Case details including demographic, 
hospitalisation and basic laboratory data 
were entered into the Tasmanian Notifiable 
Disease Database (TNDD). 
For this retrospective descriptive analysis of 
notified cases, data were extracted from the 
TNDD into Excel (Microsoft, Version 16, 2016). 
Original case reports were reviewed, and 
additional data not recorded in the TNDD, 
including clinical details, tick bite exposure, 
previous rickettsial disease, travel history, and 
detailed laboratory data, were added to the 
dataset.
Laboratory investigations
All cases had immunoglobulin G (IgG)-specific 
antibody titres against Rickettsia antigen 
performed by indirect immunofluorescence 
assay (IFA). Testing varied depending on 
which pathology provider was used. The 
majority were tested for spotted fever group 
(SFG), typhus group (TG) and scrub typhus 
group (STG). SFG antigen included R. australis 
(Queensland Tick Typhus), R. honei (FISF), and 
R. africae (African Tick Bite Fever); TG antigen 
included R. typhi (murine typhus); and STG 
included Orientia tsutsugamushi. Seven 
cases had one or both samples tested at the 
Australian Rickettsial Reference Laboratory 
in Geelong, and had titres against specific 
antigens, rather than groups. These included 
R. australis (Queensland Tick Typhus), R. honei 
(FISF), R conorii (Mediterranean Spotted 
Fever), R. africae (African Tick Bite Fever) R. 
rickettsii (Rocky Mountain Spotted Fever) and 
R. felis (cat flea typhus/Flea-borne Spotted 
Fever) in the SFG; R. typhi (murine typhus) 
and R. prowazekii (Epidemic typhus) in the 
TG; and Orientia tsutsugamushi and O. chuto 
in the STG. IgG titres ≥1:128 were considered 
positive.
Data analysis
Descriptive data analysis was performed 
exploring patterns over time, age and sex 
distribution, geographic distribution, and 
clinical and laboratory features of confirmed, 
probable, and possible cases. Population rates 
were calculated using the Australian Bureau 
of Statistics mid-year Tasmanian population 
estimate for each year.3 Data were analysed 
in Stata/IC (StataCorp LLC, Texas USA, Version 
15.0). Likely place of acquisition was assessed 
based on residential location and report of 
overseas, interstate, and intrastate travel in 
the 10 days prior to onset of illness. Likely 
place of acquisition was mapped using 
ArcMap (ESRI, Version 10.6, 2018).
Ethics
Data were collected under the provisions of 
the Public Health Act of Tasmania (1997), and 
the data analysis and report with the approval 
of the Australian National University Ethics 
Committee (Protocol 2017/909).
Results
There were 47 rickettsiosis cases in the 
TNDD notified between 1 January 2012 and 
31 December 2017. Of these, 19 did not 
meet a case definition and five were repeat 
notifications. Three cases likely acquired 
outside of Tasmania were excluded: one 
acquired in South Africa, one acquired 
in Western Australia, and one acquired 
in the Northern Territory or Queensland. 
Additionally, two cases where travel history 
was unknown were excluded. Eighteen cases 
were included in the analysis.
Figure 1: Blotched blue-tongue lizard (Tiliqua nigrolutea) with Southern Reptile Ticks (Bothriocroton hydrosauri), 
Flinders Island, Tasmania.
Photo courtesy of Robert Stewart.
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Laboratory investigations
Fourteen cases (78%) had two blood samples 
taken for IFA and four (22%) had one. The 
median time between onset of illness and 
the first serology sample was four days (range 
0–42 days) and the median time between first 
and second serology samples was 14.5 days 
(range 4–43 days).
Twelve (67%) cases demonstrated 
seroconversion or a fourfold or greater rise 
in antibody titre to either SFG or multiple 
Rickettsia species and were classified as 
confirmed cases. An additional four cases 
(22%) had single high titres and were 
classified as probable cases (cases 2, 3, 10 and 
11). Two cases (11%) had low titres (1:128) 
and were classified as possible cases (cases 4 
& 18; Table 1). 
In the six cases who had IFA against individual 
species rather than groups, there was 
evidence of significant cross-reactivity, with 
all cases having positive titres of the same 
dilution against several species, including R. 
honei (Table 1). 
Incidence and patterns over time
A mean of 3.0 cases per year were notified 
between 2012 and 2017 (range 2 to 4; Figure 
2). The mean annual rate of notification was 
0.6 per 100,000 population/year (range 0.4 to 
0.8 per 100,000 population/year).
The date of onset rather than date of 
notification is shown in Figure 2 (one 
case notified in January 2012 had onset 
in December 2011). There was a distinct 
seasonal pattern, with 11 of the 17 cases with 
onset during the years 2012 to 2017 (where 
a full calendar year was included) occurring 
in the last quarter of the year (mostly in 
November and December), four with onset 
in the first quarter and only two in either the 
second or third quarter.
An increase in notifications was noted in 
the late 2017, with five cases with onset in 
the last quarter of 2017 (Figure 2). Three 
confirmed and one probable case were part 
of an identified cluster on Flinders Island, with 
dates of onset between 4 and 27 November 
2017. 
Demographic characteristics
Twelve cases (67%) were male and six (33%) 
were female. The median age was 60 years 
(range 35–77 years). Indigenous status 
was unknown for seven cases but, among 
the remaining 11, none reported being 
Aboriginal and/or Torres Strait Islander.
Table 1:  Summary of serology results and cases classification, by case.
Case 
number





IgG titre against Rickettsia antigen by IFA Case 
classification
1 Q4, 2011 2 Four-fold increase to SFG (1:512 and 1:8192) Confirmed
2 Q1, 2012 1 Single positive titre to SFG (1:4096) and TG (1:128) Probable
3 Q1, 2012 1 Single positive titre to SFG (1:1024) Probable
4 Q3, 2013 1 Single positive titres to multiple species: R. australis, R. honei, R. conorii, 
R. africae, R. rickettsii (1:128 to all) 
Possible
5 Q4, 2013 2 Seroconversion to multiple species: R. australis, R. honei, R. conorii, R. 
africae, R. rickettsii (1:256 to all)
Confirmed
6 Q4, 2013 2 Four-fold increase to SFG (1:512 and 1:8192) Confirmed
7 Q1, 2014 2 Seroconversion to SFG (negative and 1:2048) Confirmed
8 Q1, 2014 2 Seroconversion to SFG (negative and 1:2048)
Positive titres to STG (1:256 and 1:128)
Confirmed
9 Q2, 2014 2 Seroconversion to multiple species: R. australis (≥1:1024), R. honei 
(≥1:1024), R. conorii (1:256), R. africae (1:256), R. rickettsii (1:256),  
R. felis (1:128), R. prowazekii (1:256), R. typhi (1:128)
Confirmed
10 Q4, 2014 2 Positive titre to SFG on two samples with no seroconversion (1:2048 and 
1:2048)
Probable
11 Q4, 2015 2 Positive titre to SFG on two samples with no seroconversion (1:16384 
and 1:32768)
Positive titre to TG with no seroconversion (1: 256 and 1:256)
Probable
12 Q4, 2015 2 Seroconversion to SFG (negative and 1:1024) Confirmed
13 Q4, 2016 2 Seroconversion to multiple species: R. australis (≥1:1024), R. honei 
(≥1:1024), R. conorii (≥1:1024), R. africae (≥1:1024), R. rickettsii 
(≥1:1024), R. felis (≥1:1024)
Confirmed
14 Q4, 2016 2 Seroconversion to SFG (negative to 1:4096)
Positive titres to STG (1:256 and 1:128)
Confirmed
15 Q4, 2017 2 Seroconversion to SFG (negative to 1:8192) Confirmed
16 Q4, 2017 2 Seroconversion to SFG (negative to 1:1024) Confirmed
17 Q4, 2017 2 Seroconversion to multiple species: R. australis (≥1:1024), R. honei 
(≥1:1024), R. conorii (≥1:1024), R. africae (≥1:1024), R. rickettsii 
(≥1:1024), R. felis (1:256), R. prowazekii (≥1:1024), R. typhi (≥1:1024)
Confirmed
18 Q4, 2017 1 Single positive titres to multiple species: R. australis, R. honei, R. rickettsii, 
R. felis, R. prowazekii, R. typhi (1:128 to all)
Possible
Thirteen of the cases provided their 
occupation, with five retired (28%), and four 
working on farms (31%). Other reported 
occupations included a bulldozer driver, a 
welder, a retailer and a teacher. 
Clinical characteristics
All but one case (95%) reported fever. Other 
commonly reported symptoms were lethargy 
(89%), rash (83%), myalgia and/or arthralgia 
(72%), and headache (72%), see Table 2. 
Unsolicited reported symptoms included 
chills and/or sweats (n=3), itchiness (n=1), 
shortness of breath (n=1), anorexia (n=1), 
nausea (n=1), sore throat (n=1), dry mouth 
(n=1) and photophobia (n=1).
A description was given for seven of the 15 
persons with a rash and included ‘widespread’ 
or ‘full body’ (n=3), ‘full body sparing face and 
hands’ (n=1), ‘purpuric rash lower legs’ (n=1), 
and ‘mainly on trunk with patches on legs’ 
(n=1). One confirmed case reported being red 
and swollen at the location of a suspected tick 
bite. A description was given for four of the 
13 cases with myalgia and/or arthralgia and 
included ‘aches whole body’, ‘ankle pain and 
swelling’, ‘all joints’, and ‘arthralgia of knees, 
shoulders, and fingers’. 
Six cases (33%) reported a tick bite, while 
three (17%) reported a bite of unknown 
origin. Hospitalisation status was known for 
eight cases, with five reporting hospitalisation 
and three reporting no hospitalisation. No 
cases died of their disease. 
Place of acquisition
Thirteen cases were likely acquired on 
Flinders Island (11 residents and 2 visitors), 
Table 2: Clinical presentation of cases (n=18).
Symptom
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to mild illness or other factors; clinical 
presentation is similar to many other illnesses, 
particularly viral infections; and – perhaps 
most importantly – to diagnose rickettsial 
infection, the clinician must first consider 
it in their differential diagnosis and order 
the appropriate laboratory tests. Making 
the diagnostic connection may be further 
hindered by the patient not reporting a tick 
bite. In this sample, only 50% reported a bite 
of any kind, and only 30% a tick bite. 
Tasmania is a popular tourist destination, 
with 1.26 million visitors in the year ending 
December 2017,16 and an estimated 1,500 
adults holidaying on Flinders Island per 
year.17{Tourism Tasmania, 2009 #172} A high 
proportion of visitors undertake outdoor 
activities that may put them at risk of tick 
bites.18 Although it is likely that some 
visitors to Tasmania will develop rickettsial 
disease, they may seek medical advice 
after leaving the island. Treating clinicians 
outside of Tasmania may not be aware of 
the risk and not perform the appropriate 
tests. Additionally, as rickettsial infection is 
not nationally notifiable, many infections 
acquired by visitors are unlikely to be 
captured in the surveillance systems of other 
jurisdictions. 
Despite being often described as a mild 
illness,2 FISF can be severe. Recently, the 
death of a middle-aged woman due to acute 
infection of R. honei has been described in 
Queensland,19 and another severe case was 
reported in New South Wales that required 
intensive care (Dr Stephen R. Graves, personal 
communication). In our surveillance data, 
half of cases with hospitalisation status 
reported were hospitalised. This proportion 
may overestimate true hospitalisation rates, 
due to the likelihood that this sample is 
biased towards severe disease. Although 
much is still unknown about the causes of 
severe disease and complications, treatment 
with doxycycline may reduce the risk.2 
Furthermore, prompt treatment is likely 
to reduce burden of disease as duration of 
illness without treatment is approximately 19 
days but can be as long as six weeks.7 
This work sheds new light on the 
geographical distribution of rickettsial 
infection in Tasmania. Previously cases of 
FISF in Tasmania have been described only 
on Flinders Island,7 and Schouten Island off 
the Freycinet Peninsula on the east coast 
of Tasmania,11 with one case of rickettsial 
infection, assumed to be R. honei, acquired 
on the Freycinet Peninsula or Maria Island,15 
Figure 3: Likely place of acquisition of rickettsial infection cases, Tasmania, 2012-2017.
Figure 2: Epidemic curve of notified rickettsial infection cases, Tasmania, 2012-2017.
with nine being confirmed, two probable, 
and two possible. Three cases were likely 
acquired around Great Oyster Bay: one in 
Swansea (probable), one in Dolphin Sands 
(probable), and one in Coles Bay (confirmed). 
Two further cases were likely acquired in the 
Midlands: one in Ross (confirmed) and one in 
Tunnack (confirmed), see Figure 3. Two of the 
cases acquired around Great Oyster Bay had 
onset of illness in the first quarter of 2012 and 
the cases in the Midlands had onset of illness 
in the first and second quarter of 2014. 
Discussion
Between 2012 and 2017 inclusive, a total of 18 
confirmed, probable and possible rickettsial 
infection cases were notified in Tasmania 
that were likely acquired in the state, at a 
rate of 0.6 per 100,000 population/year. This 
number may significantly underestimate 
the true incidence of cases occurring in the 
community, due to the limitations inherent 
with passive surveillance data. Some cases 
may not have sought medical advice due 
Willis et al. Article
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an island further down the east coast (Figure 
3). As the invertebrate host Bothriocroton 
hydrosauri is distributed throughout 
Tasmania,20 it has been postulated that FISF 
is likely to be distributed more widely, but 
this is the first published evidence of cases 
likely acquired outside of these locations. Of 
note, this is the first description of cases likely 
acquired in other locations around Great 
Oyster Bay and of confirmed cases in the 
Midlands. A significant limitation of the data, 
however, is that there may be testing bias, 
with clinicians in areas with known previous 
cases more likely to consider rickettsiosis 
and test for it. Our impression is that there is 
high awareness of rickettsial infection among 
medical practitioners and the community on 
Flinders Island, but less awareness elsewhere 
in Tasmania.
The seasonal pattern is consistent with 
previous literature and is not unexpected, 
as summer is when reptiles are most active 
and humans are likely to spend more time 
outdoors, increasing the risk of tick bites. 
During the cluster of cases on Flinders Island 
in November 2017, there were anecdotal 
reports of residents seeing snakes and lizards 
with ‘big ticks’ on them, demonstrating the 
close proximity of humans and Southern 
Reptile Ticks. Similarly, the preponderance of 
cases among older males has been previously 
described,7,11 and is perhaps explained by a 
higher chance of them working or engaging 
in leisure activities outdoors.
The clinical picture among these cases is 
consistent with previous reports of FISF 
and particularly with Stewart’s findings in 
his case series from Flinders Island in 1991.7 
Fever, headache, myalgia and/or arthralgia, 
and rash were prominent features. As in 
our study, Stewart also reported a varying 
distribution of the rash and both blanching 
and purpuric lesions. Similarly, rickettsial 
infections occurring in Queensland have 
shown a wide variety of dermatological 
manifestations, including maculopapular, 
macular, vesicular, and purpuric rashes.21 
In our cases, there were no specific reports 
of cough or eschar, although one person 
described redness and swelling at the site 
of a suspected tick bite. This contrasts with 
Stewart’s case series, in which 46% had a 
cough and 46% had a skin lesion other than 
the rash. However, we did not specifically 
solicit these symptoms and signs, and our 
clinical data are limited by the collection of 
surveillance data via questionnaire over the 
telephone with the patient, rather than direct 
clinical history and examination. Lethargy was 
reported in 90% of cases, although duration 
could not be ascertained. Chronic fatigue has 
been previously associated with rickettsial 
infection.22,23
We assume that the 18 infections described 
in this paper represent FISF due to R. honei 
infection, based on known epidemiology 
of rickettsioses in Australia. However, given 
the significant cross-reactivity seen with 
rickettsial serology infection it is possible 
that another rickettsial species could be 
responsible for some of these cases. Ixodes 
tasmani, another tick common in Tasmania, 
has been associated with spotted fever 
elsewhere in Australia.1,24 Izzard et al.24 
found that 55% of I. tasmani ticks collected 
from Tasmanian Devils in 2005/06 were 
polymerase chain reaction (PCR) positive for 
a Rickettsia species, subsequently named 
Candidatus Rickettsia tasmanensis. This tick is 
known to bite humans, but further research 
is needed to understand whether this new 
rickettsial species is a potential human 
pathogen.3
The only preventative measure against 
rickettsial infection is to minimise exposure 
to ticks and thus reduce the risk of tick bites. 
Current advice is to wear long sleeves and 
long pants, use tick repellent on skin and 
clothes and sleep on a raised camp bed when 
camping. In an attempt to raise awareness, 
CDPU has developed a factsheet on FISF and 
has liaised with Environmental Heath Officers 
and Parks and Wildlife Service Tasmania to 
distribute information to both residents and 
visitors.25 
Based on this review, CDPU has changed 
the surveillance case definition for rickettsial 
infection in Tasmania to include those cases 
with a single high titre and clinical evidence 
as probable cases. The aim of this change 
is to have a more sensitive case definition 
that improves Tasmanian rickettsial infection 
surveillance. 
Conclusion
This review of rickettsiosis notifications 
in Tasmania between 2012 and 2017 
extends knowledge of the epidemiology 
of rickettsial infection and FISF within 
Tasmania over recent years. In particular, 
it shows that rickettsial infection can be 
acquired in locations around Great Oyster 
Bay and the Midlands area. It is possible 
that the distribution is wider still, given 
that the Southern Reptile Tick is distributed 
throughout Tasmania. These findings have 
wider relevance outside Tasmania as its many 
visitors, many of whom undertake outdoor 
activities, may also be at risk. Increased 
awareness of potential infection by clinicians 
is essential to accurately diagnose and 
appropriately treat rickettsial infections, thus 
reducing the burden of the disease. Although 
these data add to our understanding of 
the epidemiology of rickettsial infection in 
Tasmania, our knowledge in this complex 
area remains incomplete and further work 
is needed, particularly with regard to other 
potential human rickettsial pathogens.
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